Literature DB >> 16183028

Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus.

Binoy Jose1, Valentin Antoci, Allen R Zeiger, Eric Wickstrom, Noreen J Hickok.   

Abstract

Periprosthetic infections are life-threatening complications that occur in about 6% of medical device insertions. Stringent sterile techniques have reduced the incidence of infections, but many implant patients are at high risk for infection, especially the elderly, diabetic, and immune compromised. Moreover, because of low vascularity at the site of the new implant, antibiotic prophylaxis is often not effective. To address this problem, we designed a covalent modification to titanium implant surfaces to render them bactericidal. Specifically, we aminopropylated titanium, a widely used implant material and extended a tether by solid phase coupling of ethylene glycol linkers, followed by solid phase coupling of vancomycin. Vancomycin covalently attached to titanium still bound soluble bacterial peptidoglycan, reduced Staphylococcus aureus colony-forming units by 88% +/- 16% over 2 hr, and retained antibacterial activity upon a repeated challenge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183028     DOI: 10.1016/j.chembiol.2005.06.013

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  31 in total

1.  Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen-derived peptide.

Authors:  Christopher M Hofmann; James M Anderson; Roger E Marchant
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

2.  Antibacterial activity of bone allografts: comparison of a new vancomycin-tethered allograft with allograft loaded with adsorbed vancomycin.

Authors:  Constantinos Ketonis; Stephanie Barr; Irving M Shapiro; Javad Parvizi; Christopher S Adams; Noreen J Hickok
Journal:  Bone       Date:  2010-10-28       Impact factor: 4.398

3.  Surface-immobilised antimicrobial peptoids.

Authors:  Andrea R Statz; Jong Pil Park; Nathaniel P Chongsiriwatana; Annelise E Barron; Phillip B Messersmith
Journal:  Biofouling       Date:  2008       Impact factor: 3.209

4.  Chimeric peptides as implant functionalization agents for titanium alloy implants with antimicrobial properties.

Authors:  Deniz T Yucesoy; Marketa Hnilova; Kyle Boone; Paul M Arnold; Malcolm L Snead; Candan Tamerler
Journal:  JOM (1989)       Date:  2015-04       Impact factor: 2.471

Review 5.  Molecular engineering of an orthopaedic implant: from bench to bedside.

Authors:  I M Shapiro; N J Hickok; J Parvizi; S Stewart; T P Schaer
Journal:  Eur Cell Mater       Date:  2012-05-24       Impact factor: 3.942

Review 6.  The Impact of Incorporating Antimicrobials into Implant Surfaces.

Authors:  N J Hickok; I M Shapiro; A F Chen
Journal:  J Dent Res       Date:  2017-09-18       Impact factor: 6.116

7.  Covalent Immobilization of Enoxacin onto Titanium Implant Surfaces for Inhibiting Multiple Bacterial Species Infection and In Vivo Methicillin-Resistant Staphylococcus aureus Infection Prophylaxis.

Authors:  Bin'en Nie; Teng Long; Haiyong Ao; Jianliang Zhou; Tingting Tang; Bing Yue
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

8.  The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection.

Authors:  Valentin Antoci; Christopher S Adams; Javad Parvizi; Helen M Davidson; Russell J Composto; Theresa A Freeman; Eric Wickstrom; Paul Ducheyne; Donald Jungkind; Irving M Shapiro; Noreen J Hickok
Journal:  Biomaterials       Date:  2008-09-23       Impact factor: 12.479

9.  Reducing Staphylococcus aureus biofilm formation on stainless steel 316L using functionalized self-assembled monolayers.

Authors:  Kristen M Kruszewski; Laura Nistico; Mark J Longwell; Matthew J Hynes; Joshua A Maurer; Luanne Hall-Stoodley; Ellen S Gawalt
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-01-18       Impact factor: 7.328

10.  Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives.

Authors:  McKinley C Lawson; Kevin C Hoth; Cole A Deforest; Christopher N Bowman; Kristi S Anseth
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.